Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial

NCT02734407 is registered in ClinicalTrials.gov with Retina-Vitreous Associates Medical Group as lead sponsor.

NCT NCT02734407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02734407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial
Lead sponsor
Retina-Vitreous Associates Medical Group
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
September 27, 2017
Enrollment
9 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinically significant diabetic macular edema